ProKidney Corp. (PROK) Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -177.22M USD | Operating Income (Loss) |
| Revenue | (m) | |
| Cost of products and services | (m) | |
| Research and development | 130.91M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-177.22M | (m) | (m) | $130.91M | (m) | (m) |
| 2026-03-31 | $-168.55M | (m) | (m) | $120.70M | (m) | (m) |
| 2025-12-31 | $-165.01M | (m) | (m) | $114.12M | (m) | (m) |
| 2025-09-30 | $-171.21M | (m) | (m) | $119.75M | (m) | (m) |
| 2025-06-30 | $-181.64M | (m) | (m) | $124.18M | (m) | (m) |
| 2025-03-31 | $-184.99M | (m) | (m) | $127.70M | (m) | (m) |
| 2024-12-31 | $-183.68M | (m) | (m) | $127.67M | (m) | (m) |
| 2024-09-30 | $-156.31M | (m) | (m) | $110.42M | (m) | (m) |
| 2024-06-30 | $-153.96M | (m) | (m) | $111.36M | (m) | (m) |
| 2024-03-31 | $-150.72M | (m) | (m) | $108.32M | (m) | (m) |
| 2023-12-31 | $-151.52M | (m) | (m) | $106.71M | (m) | (m) |
| 2023-09-30 | $-157.55M | (m) | (m) | $105.07M | (m) | (m) |
| 2023-06-30 | $-146.50M | (m) | (m) | $94.00M | (m) | (m) |
| 2023-03-31 | $-127.42M | (m) | (m) | $79.20M | (m) | (m) |
| 2022-12-31 | $-153.01M | (m) | (m) | $82.07M | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $-27.02M | (m) | (m) | $21.04M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.